- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-FLCN
FLCN Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IP, IHC, ELISA
Conjugaison
Non conjugué
N° de cat : 11236-2-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A431, cellules HEK-293, cellules HeLa, cellules NCCIT |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 2 publications below |
WB | See 5 publications below |
IHC | See 1 publications below |
IP | See 1 publications below |
Informations sur le produit
11236-2-AP cible FLCN dans les applications de WB, IP, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | FLCN Protéine recombinante Ag1746 |
Nom complet | folliculin |
Masse moléculaire calculée | 38 kDa |
Poids moléculaire observé | 64-75 kDa |
Numéro d’acquisition GenBank | BC015687 |
Symbole du gène | FLCN |
Identification du gène (NCBI) | 201163 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
FLCN, also named as BHD, belongs to the folliculin family. It may play a role in the pathogenesis of an uncommon form of kidney cancer through its association with an inherited disorder of the hair follicle (fibrofolliculomas). FLCN may be a tumor suppressor. It is involved in colorectal tumorigenesis. It may be involved in energy and/or nutrient sensing through the AMPK and mTOR signaling pathways. Mutation of FLCN may cause the BHD(Birt-Hogg-Dube syndrome ) or (PSP) primary spontaneous pneumothorax. And it may be involved in renal cell carcinoma.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for FLCN antibody 11236-2-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
FASEB J AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR. | ||
DNA Repair (Amst) Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA.
| ||
Front Mol Biosci FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma. | ||
J Trace Elem Med Biol Methionine-chelated Zn promotes anabolism by integrating mTOR signal and autophagy pathway in juvenile yellow catfish. | ||
Biochem Biophys Res Commun Stabilization of MAPO1 by specific binding with folliculin and AMP-activated protein kinase in O?-methylguanine-induced apoptosis.
| ||
Curr Res Neurobiol Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models |